| Paper |
Title |
Page |
| TUZG01 |
IFMIF: Status and Developments
|
974 |
| |
- P. Garin
CEA, Gif-sur-Yvette
|
|
| |
On the way to the fusion demonstrator (DEMO), ITER is designed to tackle the physics properties of thermonuclear plasmas in relevant conditions, as well as the key technologies. But because of its experimental character, the amount of neutrons produced by ITER all along its life will be about two orders of magnitude below what is expected in a fusion Power Plant. A dedicated facility, called IFMIF (International Fusion Materials Irradiation Facility), is thus mandatory to study and analyse the behaviour of materials under a high flux of energetic neutrons (14 MeV). The Engineering Validation and Engineering Design Activities (EVEDA), launched in the framework of a bilateral agreement between Euratom and the Government of Japan in 2007, with a duration of 6 years, aims at producing the detailed design file enabling the construction of IFMIF. The key systems will be also tested during this phase. One of the most important one is the accelerator, bringing a deuteron beam of 125 mA to an output energy of 40 MeV. The whole facility will be described, including the detail of the accelerator, as well as the organisational framework of the project.
|
|
|
Slides
|
|
| TUZG02 |
Status of Hadrontherapy Facilities Worldwide
|
978 |
| |
- E. S. Pedroni
PSI, Villigen
|
|
| |
Especially within the last years a remarkable dynamics can be observed with respect to the realization of new hadrontherapy facilities. The reasons are the development of new treatment modalities like pencil beam scanning, but also commercial aspects, arising from the number of patients that would profit from this treatment and the according demand of such facilities. The interest of industrial firms in constructing and operating 'turn-key' facilities has increased and at present several firms provide such facilities for proton treatment as well as for light ion (and proton) treatments. This presentation gives an overview of basic biophysical properties and the treatment modalities, the status of existing and planned facilities as well as developments on this field.
|
|
|
|
Slides
|
|